Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Quinie Balm - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Quinie Balm

Approved

STANDARD

Quinie Balm

Azarias Pharmaceutical Laboratories🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 28c852c3517bfbbb
Company: Azarias Pharmaceutical Laboratories
Type: Standard

Approval Details

Approval Id: 28c852c3517bfbbb
Drug Approval Philippines Name: Quinie Balm
Product Name: Quinie Balm
Registration Number: HRP-304
Brand Name: Quinie Balm
Generic Name: Camphor + Menthol + Methyl Salicylate
Dosage Form: Ointment
Dosage Strength: 40 mg/ 50 mg/200 mg per gram
Manufacturer: Azarias Pharmaceutical Laboratories
Issuance Date: 26 February 2024
Expiry Date: 19 March 2029
Pharmacologic Category: Rubefacient/Counterirritant
Classification: Household Remedy (HR)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

28c852c3517bfbbb

Type

Standard

Back to Philippines FDA Approvals